HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Breakthrough medical platform offers vision of personalized tumor treatments with its novel sonic beam therapy ANN ARBOR, Mich., April 8, 2019 -- (Healthcare Sales & Marketing Network) -- HistoSonics, developer of a non-invasive robotics platform and n... Devices, Venture Capital HistoSonics, Robotically Assisted Sonic Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news